PMID: 16629485Apr 25, 2006Paper

Effective combined modality therapy for a patient with primary adrenal lymphoma

[Rinshō ketsueki] The Japanese journal of clinical hematology
Sayaka ShiraoKyuhei Kohda

Abstract

Primary adrenal lymphoma is a rare lymphoma with clinical features consisting of a high incidence of bilateral adrenal involvement, diffuse large B-cell histology and secondary adrenal insufficiency. We report a successful treatment of a patient with primary adrenal lymphoma using a combined modality therapy (CMT). A 62-year-old man was hospitalized with pain of the flank, and a computed tomography (CT) scan of the abdomen revealed very large, bilateral adrenal masses. A needle biopsy of the left adrenal mass revealed diffuse large B-cell lymphoma. After irradiation of both adrenal lymphomas and CHOP therapy accompanied by intrathecal treatment and rituximab, the patient underwent a left adrenalectomy and high-dose chemotherapy with autologous peripheral blood stem cell transplantation. The patient has been disease-free for 2 years after the diagnosis of primary adrenal lymphoma. In contrast to the previous reports of poor response to conventional-dose chemotherapy alone and short-term survival of patients with primary adrenal lymphoma, our patient has demonstrated that radiation therapy combined with chemotherapy and rituximab may be an effective modality as a first-line therapeutic regimen for localized primary adrenal lymphoma.

Related Concepts

Related Feeds

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology
Ali EzerSedat Yildirim
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Abdullah Ladha, Ghulam Haider
Dermatology : International Journal for Clinical and Investigative Dermatology
Robert FeldmannFriedrich Breier
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet
Tada KunavisarutNoppadol Siritanratkul
Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging
Thomas G Trautmann, James H Zuger
© 2022 Meta ULC. All rights reserved